• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Affinity maturation in a human humoral response to influenza hemagglutinin

tetano

Editor, Senior Moderator
Proc Natl Acad Sci U S A. 2019 Dec 16. pii: 201915620. doi: 10.1073/pnas.1915620116. [Epub ahead of print] [h=1]Affinity maturation in a human humoral response to influenza hemagglutinin.[/h]
McCarthy KR[SUP]1[/SUP], Raymond DD[SUP]1[/SUP], Do KT[SUP]1[/SUP], Schmidt AG[SUP]1,[/SUP][SUP]2,[/SUP][SUP]3[/SUP], Harrison SC[SUP]4,[/SUP][SUP]5[/SUP].
[h=3]Author information[/h] 1 Laboratory of Molecular Medicine, Boston Children's Hospital and Harvard Medical School, Boston, MA 02115. 2 Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard, Cambridge, MA 02139. 3 Harvard Medical School, Boston, MA 02115. 4 Laboratory of Molecular Medicine, Boston Children's Hospital and Harvard Medical School, Boston, MA 02115; harrison@crystal.harvard.edu. 5 Howard Hughes Medical Institute, Harvard Medical School, Boston, MA 02115.

[h=3]Abstract[/h] Affinity maturation of the B cell antigen receptor (BCR) is a conserved and crucial component of the adaptive immune response. BCR lineages, inferred from paired heavy- and light-chain sequences of rearranged Ig genes from multiple descendants of the same naive B cell precursor (the lineages' unmutated common ancestor, "UCA"), make it possible to reconstruct the underlying somatic evolutionary history. We present here an extensive structural and biophysical analysis of a lineage of BCRs directed against the receptor binding site (RBS) of subtype H1 influenza virus hemagglutinin (HA). The lineage includes 8 antibodies detected directly by sequencing, 3 in 1 principal branch and 5 in the other. When bound to HA, the heavy-chain third complementarity determining region (HCDR3) fits with an invariant pose into the RBS, but in each of the 2 branches, the rest of the Fab reorients specifically, from its position in the HA-bound UCA, about a hinge at the base of HCDR3. New contacts generated by the reorientation compensate for contacts lost as the H1 HA mutated during the time between the donor's initial exposure and the vaccination that preceded sampling. Our data indicate that a "pluripotent" naive response differentiated, in each branch, into 1 of its possible alternatives. This property of naive BCRs and persistence of multiple branches of their progeny lineages can offer broader protection from evolving pathogens than can a single, linear pathway of somatic mutation.
Copyright ? 2019 the Author(s). Published by PNAS.


[h=4]KEYWORDS:[/h] B cell; X-ray crystallography; antibody; influenza virus; vaccine

PMID: 31843892 DOI: 10.1073/pnas.1915620116
Free full text
 
Back
Top Bottom